Coagulation activation in Type 2 diabetes mellitus the higher coronary risk of female diabetic patients

P. Chan, W. H. Pan

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Thrombophilia in diabetic patients is a well-recognized phenomenon which constitutes an additional risk of coronary heart disease. This study included 1980 ethnic Chinese people (835 male, 1145 female); age range: 45 to 69 years, including 280 Type 2 diabetic patients (male 125, female 155). Haemostatic parameters measured were fibrinogen, prothrombin time, activated partial thromboplastin time (APTT), factor VIIc, factor VIIIc, antithrombin III, and plasminogen. Compared with a control group, male diabetic patients showed significantly shorter APTT (25.6 ± 3.7 vs 27.5 ± 3.6 s, p <0.01), and elevated factor VIIIc (171.1 ± 77.48 vs 131.16 ± 52.23%, p <0.0001), whereas female diabetic patients showed significantly shorter APTT (24.9 ± 4.2 vs 26.5 ± 3.9 s, p <0.001) and elevated fibrinogen (10.6 ± 3.3 vs 9.8 ± 2.6 μmol 1-1, p

Original languageEnglish
Pages (from-to)504-507
Number of pages4
JournalDiabetic Medicine
Volume12
Issue number6
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Partial Thromboplastin Time
Fibrinogen
Thrombophilia
Antithrombin III
Plasminogen
Prothrombin Time
Hemostatics
Coronary Disease
Control Groups

Keywords

  • Coagulation
  • Coronary risk factor
  • Type 2 diabetes mellitis

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Coagulation activation in Type 2 diabetes mellitus the higher coronary risk of female diabetic patients. / Chan, P.; Pan, W. H.

In: Diabetic Medicine, Vol. 12, No. 6, 1995, p. 504-507.

Research output: Contribution to journalArticle

@article{c83cdc6196f84cd09c59faa960f8e353,
title = "Coagulation activation in Type 2 diabetes mellitus the higher coronary risk of female diabetic patients",
abstract = "Thrombophilia in diabetic patients is a well-recognized phenomenon which constitutes an additional risk of coronary heart disease. This study included 1980 ethnic Chinese people (835 male, 1145 female); age range: 45 to 69 years, including 280 Type 2 diabetic patients (male 125, female 155). Haemostatic parameters measured were fibrinogen, prothrombin time, activated partial thromboplastin time (APTT), factor VIIc, factor VIIIc, antithrombin III, and plasminogen. Compared with a control group, male diabetic patients showed significantly shorter APTT (25.6 ± 3.7 vs 27.5 ± 3.6 s, p <0.01), and elevated factor VIIIc (171.1 ± 77.48 vs 131.16 ± 52.23{\%}, p <0.0001), whereas female diabetic patients showed significantly shorter APTT (24.9 ± 4.2 vs 26.5 ± 3.9 s, p <0.001) and elevated fibrinogen (10.6 ± 3.3 vs 9.8 ± 2.6 μmol 1-1, p",
keywords = "Coagulation, Coronary risk factor, Type 2 diabetes mellitis",
author = "P. Chan and Pan, {W. H.}",
year = "1995",
language = "English",
volume = "12",
pages = "504--507",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Coagulation activation in Type 2 diabetes mellitus the higher coronary risk of female diabetic patients

AU - Chan, P.

AU - Pan, W. H.

PY - 1995

Y1 - 1995

N2 - Thrombophilia in diabetic patients is a well-recognized phenomenon which constitutes an additional risk of coronary heart disease. This study included 1980 ethnic Chinese people (835 male, 1145 female); age range: 45 to 69 years, including 280 Type 2 diabetic patients (male 125, female 155). Haemostatic parameters measured were fibrinogen, prothrombin time, activated partial thromboplastin time (APTT), factor VIIc, factor VIIIc, antithrombin III, and plasminogen. Compared with a control group, male diabetic patients showed significantly shorter APTT (25.6 ± 3.7 vs 27.5 ± 3.6 s, p <0.01), and elevated factor VIIIc (171.1 ± 77.48 vs 131.16 ± 52.23%, p <0.0001), whereas female diabetic patients showed significantly shorter APTT (24.9 ± 4.2 vs 26.5 ± 3.9 s, p <0.001) and elevated fibrinogen (10.6 ± 3.3 vs 9.8 ± 2.6 μmol 1-1, p

AB - Thrombophilia in diabetic patients is a well-recognized phenomenon which constitutes an additional risk of coronary heart disease. This study included 1980 ethnic Chinese people (835 male, 1145 female); age range: 45 to 69 years, including 280 Type 2 diabetic patients (male 125, female 155). Haemostatic parameters measured were fibrinogen, prothrombin time, activated partial thromboplastin time (APTT), factor VIIc, factor VIIIc, antithrombin III, and plasminogen. Compared with a control group, male diabetic patients showed significantly shorter APTT (25.6 ± 3.7 vs 27.5 ± 3.6 s, p <0.01), and elevated factor VIIIc (171.1 ± 77.48 vs 131.16 ± 52.23%, p <0.0001), whereas female diabetic patients showed significantly shorter APTT (24.9 ± 4.2 vs 26.5 ± 3.9 s, p <0.001) and elevated fibrinogen (10.6 ± 3.3 vs 9.8 ± 2.6 μmol 1-1, p

KW - Coagulation

KW - Coronary risk factor

KW - Type 2 diabetes mellitis

UR - http://www.scopus.com/inward/record.url?scp=0029030689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029030689&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 504

EP - 507

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 6

ER -